{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:22:33Z","timestamp":1790673753192,"version":"4.1.0"},"reference-count":127,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union\u2019s Horizon 2020 research and innovation programme under Marie Sk\u0142odowska-Curie","award":["765608"],"award-info":[{"award-number":["765608"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme under Marie Sk\u0142odowska-Curie","award":["44874"],"award-info":[{"award-number":["44874"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme under Marie Sk\u0142odowska-Curie","award":["44875"],"award-info":[{"award-number":["44875"]}]},{"name":"University of Antwerp","award":["765608"],"award-info":[{"award-number":["765608"]}]},{"name":"University of Antwerp","award":["44874"],"award-info":[{"award-number":["44874"]}]},{"name":"University of Antwerp","award":["44875"],"award-info":[{"award-number":["44875"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Dry eye disease (DED) is a multifactorial disorder that leads to ocular discomfort, visual disturbance, and tear film instability. DED is accompanied by an increase in tear osmolarity and ocular surface inflammation. The diagnosis and treatment of DED still present significant challenges. Therefore, novel biomarkers and treatments are of great interest. Proteases are present in different tissues on the ocular surface. In a healthy eye, proteases are highly regulated. However, dysregulation occurs in various pathologies, including DED. With this review, we provide an overview of the implications of different families of proteases in the development and severity of DED, along with studies involving protease inhibitors as potential therapeutic tools. Even though further research is needed, this review aims to give suggestions for identifying novel biomarkers and developing new protease inhibitors.<\/jats:p>","DOI":"10.3390\/ijms23179795","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T21:01:31Z","timestamp":1661806891000},"page":"9795","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Proteases and Their Potential Role as Biomarkers and Drug Targets in Dry Eye Disease and Ocular Surface Dysfunction"],"prefix":"10.3390","volume":"23","author":[{"given":"Alba","family":"Ramos-Llorca","sequence":"first","affiliation":[{"name":"Laboratory of Medicinal Chemistry, Department of Pharmaceutical Sciences, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Campus Drie Eiken, University of Antwerp, Universiteitsplein 1, B-2160 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1860-6532","authenticated-orcid":false,"given":"Camilla","family":"Scarpellini","sequence":"additional","affiliation":[{"name":"Laboratory of Medicinal Chemistry, Department of Pharmaceutical Sciences, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Campus Drie Eiken, University of Antwerp, Universiteitsplein 1, B-2160 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9523-2928","authenticated-orcid":false,"given":"Koen","family":"Augustyns","sequence":"additional","affiliation":[{"name":"Laboratory of Medicinal Chemistry, Department of Pharmaceutical Sciences, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Campus Drie Eiken, University of Antwerp, Universiteitsplein 1, B-2160 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II Definition and Classification Report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jtos.2018.11.003","article-title":"The Impact of Dry Eye Disease Treatment on Patient Satisfaction and Quality of Life: A Review","volume":"17","author":"Gomes","year":"2019","journal-title":"Ocul. Surf."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jtos.2016.04.005","article-title":"Understanding Symptoms and Quality of Life in Patients With Dry Eye Syndrome","volume":"14","author":"Barabino","year":"2016","journal-title":"Ocul. Surf."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/NHH.0000000000000652","article-title":"Dry Eye Disease","volume":"36","author":"Rouen","year":"2018","journal-title":"Home Healthc. Now"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II Epidemiology Report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2147\/CIA.S140912","article-title":"Sex Differences in the Effect of Aging on Dry Eye Disease","volume":"12","author":"Ahn","year":"2017","journal-title":"Clin. Interv. Aging"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s40123-020-00308-z","article-title":"Dry Eye Disease: Early Recognition with Guidance on Management and Treatment for Primary Care Family Physicians","volume":"9","author":"Verjee","year":"2020","journal-title":"Ophthalmol. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.5455\/medarh.2021.75.144-148","article-title":"Mask-Associated Dry Eye During COVID-19 Pandemic-How Face Masks Contribute to Dry Eye Disease Symptoms","volume":"75","author":"Krolo","year":"2021","journal-title":"Med. Arch."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"101408","DOI":"10.1016\/j.clae.2021.01.003","article-title":"Self-Reported Symptoms of Mask-Associated Dry Eye: A Survey Study of 3605 People","volume":"45","author":"Boccardo","year":"2022","journal-title":"Contact Lens Anterior Eye"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2532314","DOI":"10.1155\/2018\/2532314","article-title":"Innate and Adaptive Cell Populations Driving Inflammation in Dry Eye Disease","volume":"2018","author":"Reyes","year":"2018","journal-title":"Mediators Inflamm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1749-6632.2002.tb04217.x","article-title":"Androgen Deficiency, Meibomian Gland Dysfunction, and Evaporative Dry Eye","volume":"966","author":"Sullivan","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jtos.2021.03.006","article-title":"Human Precorneal Tear Film and Lipid Layer Dynamics in Meibomian Gland Dysfunction","volume":"21","author":"Bai","year":"2021","journal-title":"Ocul. Surf."},{"key":"ref_13","first-page":"71","article-title":"The Pathophysiology, Diagnosis, and Treatment of Dry Eye Disease","volume":"112","author":"Messmer","year":"2015","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren Syndrome","volume":"2","author":"Baldini","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","article-title":"Revisiting the Vicious Circle of Dry Eye Disease: A Focus on the Pathophysiology of Meibomian Gland Dysfunction","volume":"100","author":"Baudouin","year":"2016","journal-title":"Br. J. Ophthalmol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S1542-0124(12)70148-9","article-title":"Inflammation in Dry Eye","volume":"2","author":"Stern","year":"2004","journal-title":"Ocul. Surf."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II Pathophysiology Report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II Diagnostic Methodology Report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","article-title":"Dry Eye Disease","volume":"130","author":"Stevenson","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/tjo.tjo_56_19","article-title":"Role of Tear Film Biomarkers in the Diagnosis and Management of Dry Eye Disease","volume":"9","author":"Fong","year":"2019","journal-title":"Taiwan J. Ophthalmol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II Management and Therapy Report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ajo.2003.10.036","article-title":"Antiinflammatory Therapy for Dry Eye","volume":"137","author":"Pflugfelder","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/archopht.118.11.1489","article-title":"Analysis of Topical Cyclosporine Treatment of Patients with Dry Eye SyndromeEffect on Conjunctival Lymphocytes","volume":"118","author":"Kunert","year":"2000","journal-title":"Arch. Ophthalmol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2147\/OPTH.S110557","article-title":"Development of Lifitegrast: A Novel T-Cell Inhibitor for the Treatment of Dry Eye Disease","volume":"10","author":"Semba","year":"2016","journal-title":"Clin. Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1358\/dot.2022.58.2.3367993","article-title":"Loteprednol Etabonate: A Formulation for Short-Term Use in Inflammatory Flares in Dry Eye Disease","volume":"58","author":"Paton","year":"2022","journal-title":"Drugs of Today"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/gb-2006-7-6-r50","article-title":"Identification of 491 Proteins in the Tear Fluid Proteome Reveals a Large Number of Proteases and Protease Inhibitors","volume":"7","author":"Godoy","year":"2006","journal-title":"Genome Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.genet.38.072902.093416","article-title":"Proteolysis as a Regulatory Mechanism","volume":"38","author":"Ehrmann","year":"2004","journal-title":"Annu. Rev. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1074\/jbc.TM118.004156","article-title":"Proteases: History, Discovery, and Roles in Health and Disease","volume":"294","author":"Bond","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nrg1111","article-title":"Human and Mouse Proteases: A Comparative Genomic Approach","volume":"4","author":"Puente","year":"2003","journal-title":"Nat. Rev. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"D343","DOI":"10.1093\/nar\/gkr987","article-title":"MEROPS: The Database of Proteolytic Enzymes, Their Substrates and Inhibitors","volume":"40","author":"Rawlings","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/bj2900205","article-title":"Evolutionary Families of Peptidases","volume":"290","author":"Rawlings","year":"1993","journal-title":"Biochem. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm858","article-title":"Protease Degradomics: A New Challenge for Proteomics","volume":"3","author":"Overall","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"30433","DOI":"10.1074\/jbc.R800035200","article-title":"Proteases: Multifunctional Enzymes in Life and Disease","volume":"283","author":"Bond","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd2092","article-title":"Targeting Proteases: Successes, Failures and Future Prospects","volume":"5","author":"Turk","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12959-019-0194-8","article-title":"Protease-Activated Receptors (PARs): Mechanisms of Action and Potential Therapeutic Modulators in PAR-Driven Inflammatory Diseases","volume":"17","author":"Heuberger","year":"2019","journal-title":"Thromb. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1097\/ICL.0000000000000641","article-title":"Tear Proteases and Protease Inhibitors: Potential Biomarkers and Disease Drivers in Ocular Surface Disease","volume":"46","author":"Fu","year":"2020","journal-title":"Eye Contact Lens Sci. Clin. Pract."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"108895","DOI":"10.1016\/j.exer.2021.108895","article-title":"Cathepsin S Is a Novel Target for Age-Related Dry Eye","volume":"214","author":"Yu","year":"2022","journal-title":"Exp. Eye Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"17268","DOI":"10.1038\/s41598-020-74159-w","article-title":"A Novel Serine Protease Inhibitor as Potential Treatment for Dry Eye Syndrome and Ocular Inflammation","volume":"10","author":"Joossen","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3389\/fphys.2022.880422","article-title":"Inhibition of Serine Proteases as a Novel Therapeutic Strategy for Abdominal Pain in IBS","volume":"13","author":"Decraecker","year":"2022","journal-title":"Front. Physiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.drudis.2022.03.011","article-title":"Exploiting Protease Activation for Therapy","volume":"27","author":"Bleuez","year":"2022","journal-title":"Drug Discov. Today"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/j.bmc.2007.01.011","article-title":"Matrix Metalloproteinases (MMPs): Chemical\u2013Biological Functions and (Q)SARs","volume":"15","author":"Verma","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrm2125","article-title":"Matrix Metalloproteinases and the Regulation of Tissue Remodelling","volume":"8","author":"Ewald","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1073\/pnas.87.14.5578","article-title":"The Cysteine Switch: A Principle of Regulation of Metalloproteinase Activity with Potential Applicability to the Entire Matrix Metalloproteinase Gene Family (Collagenase\/Gelatinase\/Stromelysin\/Zinc Enzyme)","volume":"87","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"108500","DOI":"10.1016\/j.exer.2021.108500","article-title":"Matrix Metalloproteinases and Their Inhibitors in Fuchs Endothelial Corneal Dystrophy","volume":"205","author":"Xu","year":"2021","journal-title":"Exp. Eye Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1167\/iovs.05-1382","article-title":"Desiccating Stress Stimulates Expression of Matrix Metalloproteinases by the Corneal Epithelium","volume":"47","author":"Corrales","year":"2006","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1167\/iovs.03-1145","article-title":"Experimental Dry Eye Stimulates Production of Inflammatory Cytokines and MMP-9 and Activates MAPK Signaling Pathways on the Ocular Surface","volume":"45","author":"Luo","year":"2004","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.exer.2006.02.004","article-title":"Corticosteroid and Doxycycline Suppress MMP-9 and Inflammatory Cytokine Expression, MAPK Activation in the Corneal Epithelium in Experimental Dry Eye","volume":"83","author":"Corrales","year":"2006","journal-title":"Exp. Eye Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1167\/iovs.19-26928","article-title":"Therapeutic Effects of STAT3 Inhibition on Experimental Murine Dry Eye","volume":"60","author":"Qu","year":"2019","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/02713680903453494","article-title":"The Therapeutic Effect of DA-6034 on Ocular Inflammation via Suppression of MMP-9 and Inflammatory Cytokines and Activation of the MAPK Signaling Pathway in an Experimental Dry Eye Model","volume":"35","author":"Seo","year":"2010","journal-title":"Curr. Eye Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0002-9440(10)62232-8","article-title":"Matrix Metalloproteinase-9 Knockout Confers Resistance to Corneal Epithelial Barrier Disruption in Experimental Dry Eye","volume":"166","author":"Pflugfelder","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Lee, Y.H., Bang, S.-P., Shim, K.-Y., Son, M.-J., Kim, H., and Jun, J.H. (2021). Association of Tear Matrix Metalloproteinase 9 Immunoassay with Signs and Symptoms of Dry Eye Disease: A Cross-Sectional Study Using Qualitative, Semiquantitative, and Quantitative Strategies. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0258203"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/ICO.0000000000000449","article-title":"Correlation of Tear Film Osmolarity and 2 Different MMP-9 Tests With Common Dry Eye Tests in a Cohort of Non\u2013Dry Eye Patients","volume":"34","author":"Schargus","year":"2015","journal-title":"Cornea"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"6132016","DOI":"10.1155\/2022\/6132016","article-title":"The Correlation between Matrix Metalloproteinase-9 Point-of-Care Immunoassay, Tear Film Osmolarity, and Ocular Surface Parameters","volume":"2022","author":"Kang","year":"2022","journal-title":"J. Ophthalmol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3341\/kjo.2019.0145","article-title":"Tear Osmolarity and Matrix Metallopeptidase-9 in Dry Eye Associated with Sj\u00f6gren\u2019s Syndrome","volume":"34","author":"Kook","year":"2020","journal-title":"Korean J. Ophthalmol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jtos.2015.10.004","article-title":"The Matrix Metalloproteinase 9 Point-of-Care Test in Dry Eye","volume":"14","author":"Lanza","year":"2016","journal-title":"Ocul. Surf."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/iub.186","article-title":"Serine Proteases","volume":"61","year":"2009","journal-title":"IUBMB Life"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/pro.5560040301","article-title":"Structural Basis of Substrate Specificity in the Serine Proteases","volume":"4","author":"Perona","year":"2008","journal-title":"Protein Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nrd3053","article-title":"Emerging Principles in Protease-Based Drug Discovery","volume":"9","author":"Drag","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1136\/gutjnl-2015-309147","article-title":"Protease Inhibition as New Therapeutic Strategy for GI Diseases","volume":"65","author":"Vergnolle","year":"2016","journal-title":"Gut"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S1357-2725(03)00134-1","article-title":"Serpins: Structure, Function and Molecular Evolution","volume":"35","author":"Sharp","year":"2003","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.molimm.2010.04.020","article-title":"Serine Proteases of the Human Immune System in Health and Disease","volume":"47","author":"Heutinck","year":"2010","journal-title":"Mol. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.yexmp.2012.09.014","article-title":"Role of Serine Proteases in Inflammation: Bowman\u2013Birk Protease Inhibitor (BBI) as a Potential Therapy for Autoimmune Diseases","volume":"93","author":"Safavi","year":"2012","journal-title":"Exp. Mol. Pathol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7834","DOI":"10.1038\/s41598-018-26282-y","article-title":"Functional Proteomic Profiling of Secreted Serine Proteases in Health and Inflammatory Bowel Disease","volume":"8","author":"Bonnart","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/02713689808951215","article-title":"Identification, Origins and the Diurnal Role of the Principal Serine Protease Inhibitors in Human Tear Fluid","volume":"17","author":"Sathe","year":"1998","journal-title":"Curr. Eye Res."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Mun, Y., Hwang, J.S., and Shin, Y.J. (2021). Role of Neutrophils on the Ocular Surface. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910386"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1164\/ajrccm\/150.6_Pt_2.S114","article-title":"The Role of Neutrophil Elastase in Chronic Inflammation","volume":"150","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.biocel.2007.11.008","article-title":"Neutrophil Serine Proteases Fine-Tune the Inflammatory Response","volume":"40","author":"Pham","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"8253","DOI":"10.1167\/iovs.12-10430","article-title":"Ocular Surface Extracellular DNA and Nuclease Activity Imbalance: A New Paradigm for Inflammation in Dry Eye Disease","volume":"53","author":"Sonawane","year":"2012","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jtos.2021.04.002","article-title":"Altered Ocular Surface Immune Cell Profile in Patients with Dry Eye Disease","volume":"21","author":"Nair","year":"2021","journal-title":"Ocul. Surf."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jtos.2020.08.011","article-title":"Enhanced Closed Eye Neutrophil Degranulation in Dry Eye Disease","volume":"18","author":"Postnikoff","year":"2020","journal-title":"Ocul. Surf."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"7961","DOI":"10.1167\/iovs.14-15332","article-title":"Hyperosmolar Stress Induces Neutrophil Extracellular Trap Formation: Implications for Dry Eye Disease","volume":"55","author":"Tibrewal","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtos.2020.12.005","article-title":"Aggregated Neutrophil Extracellular Traps Occlude Meibomian Glands during Ocular Surface Inflammation","volume":"20","author":"Mahajan","year":"2021","journal-title":"Ocul. Surf."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1398-9995.1996.tb04671.x","article-title":"Tear Tryptase Levels and Allergic Conjunctivitis","volume":"51","author":"Magrini","year":"1996","journal-title":"Allergy"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-065X.2007.00509.x","article-title":"Mast Cell Tryptases and Chymases in Inflammation and Host Defense","volume":"217","author":"Caughey","year":"2007","journal-title":"Immunol. Rev."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/S0161-6420(90)32362-X","article-title":"The Level of Tryptase in Human Tears","volume":"97","author":"Butrus","year":"1990","journal-title":"Ophthalmology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/cbf.2991","article-title":"Tryptase Compromises Corneal Epithelial Barrier Function","volume":"32","author":"Li","year":"2014","journal-title":"Cell Biochem. Funct."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/02713680500346625","article-title":"Mast Cell Chymase Decreases the Barrier Function and Inhibits the Migration of Corneal Epithelial Cells","volume":"30","author":"Ebihara","year":"2005","journal-title":"Curr. Eye Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/ACI.0000000000000471","article-title":"Ocular Allergy as a Risk Factor for Dry Eye in Adults and Children","volume":"18","author":"Villani","year":"2018","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.2174\/1381612023394124","article-title":"Regulating Cysteine Protease Activity: Essential Role of Protease Inhibitors As Guardians and Regulators","volume":"8","author":"Turk","year":"2002","journal-title":"Curr. Pharm. Des."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"D624","DOI":"10.1093\/nar\/gkx1134","article-title":"The MEROPS Database of Proteolytic Enzymes, Their Substrates and Inhibitors in 2017 and a Comparison with Peptidases in the PANTHER Database","volume":"46","author":"Rawlings","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Tu\u0161ar, L., Usenik, A., Turk, B., and Turk, D. (2021). Mechanisms Applied by Protein Inhibitors to Inhibit Cysteine Proteases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22030997"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"10994","DOI":"10.1021\/ja981792o","article-title":"Vinyl Sulfonate Esters and Vinyl Sulfonamides: Potent, Irreversible Inhibitors of Cysteine Proteases","volume":"120","author":"Roush","year":"1998","journal-title":"J. Am. Chem. Soc."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.exer.2006.05.017","article-title":"The Role of Cathepsins in Ocular Physiology and Pathology","volume":"84","author":"Im","year":"2007","journal-title":"Exp. Eye Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"118517","DOI":"10.1016\/j.bbamcr.2019.07.012","article-title":"Lysosomal Cysteine Protease Cathepsin S Is Involved in Cancer Cell Motility by Regulating Store-Operated Ca2+ Entry","volume":"1866","author":"Lin","year":"2019","journal-title":"Biochim. Biophys. Acta-Mol. Cell Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/rr29","article-title":"Importance of Lysosomal Cysteine Proteases in Lung Disease","volume":"1","author":"Wolters","year":"2000","journal-title":"Respir. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1167\/iovs.09-4523","article-title":"Increased Expression of Cathepsins and Obesity-Induced Proinflammatory Cytokines in Lacrimal Glands of Male NOD Mouse","volume":"51","author":"Li","year":"2010","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/art.38633","article-title":"Tear Cathepsin S as a Candidate Biomarker for Sj\u00f6gren\u2019s Syndrome","volume":"66","author":"Janga","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"11044","DOI":"10.1038\/s41598-018-29411-9","article-title":"Increased Cathepsin S Activity Associated with Decreased Protease Inhibitory Capacity Contributes to Altered Tear Proteins in Sj\u00f6gren\u2019s Syndrome Patients","volume":"8","author":"Edman","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1152\/physrev.00028.2003","article-title":"Protease-Activated Receptors: Contribution to Physiology and Disease","volume":"84","author":"Ossovskaya","year":"2004","journal-title":"Physiol. Rev."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.pharmthera.2011.01.003","article-title":"Structure, Function and Pathophysiology of Protease Activated Receptors","volume":"130","author":"Adams","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3389\/fendo.2019.00717","article-title":"Protease-Activated Receptors in the Intestine: Focus on Inflammation and Cancer","volume":"10","author":"Mas","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1055\/s-0037-1615617","article-title":"Neutrophil Proteases Can Inactivate Human PAR3 and Abolish the Co-Receptor Function of PAR3 on Murine Platelets","volume":"85","author":"Cumashi","year":"2001","journal-title":"Thromb. Haemost."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Price, R., Mercuri, N.B., and Ledonne, A. (2021). Emerging Roles of Protease-Activated Receptors (PARs) in the Modulation of Synaptic Transmission and Plasticity. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020869"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00281-011-0289-1","article-title":"Protease-Activated Receptor 2 Signaling in Inflammation","volume":"34","author":"Rothmeier","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/sj.bjp.0706204","article-title":"The Role of Intracellular Ca2+ in the Regulation of Proteinase-Activated Receptor-2 Mediated Nuclear Factor Kappa B Signalling in Keratinocytes","volume":"145","author":"Macfarlane","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1111\/febs.15829","article-title":"Molecular Mechanisms Regulating Proteinase-Activated Receptors (PARs)","volume":"288","author":"Chandrabalan","year":"2021","journal-title":"FEBS J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"24638","DOI":"10.1074\/jbc.M110.201988","article-title":"Neutrophil Elastase Acts as a Biased Agonist for Proteinase-Activated Receptor-2 (PAR2)","volume":"286","author":"Ramachandran","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/08830185.2012.748052","article-title":"Dry Eye as a Mucosal Autoimmune Disease","volume":"32","author":"Stern","year":"2013","journal-title":"Int. Rev. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/ajg.2013.241","article-title":"Sensitization of Peripheral Sensory Nerves by Mediators From Colonic Biopsies of Diarrhea-Predominant Irritable Bowel Syndrome Patients: A Role for PAR2","volume":"108","author":"Overington","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.vph.2005.07.009","article-title":"Protease-Activated Receptor-2 (PAR2) in Cardiovascular System","volume":"43","author":"Bucci","year":"2005","journal-title":"Vascul. Pharmacol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pharmthera.2007.04.002","article-title":"A Novel Therapeutic Target in Various Lung Diseases: Airway Proteases and Protease-Activated Receptors","volume":"115","author":"Sokolova","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1167\/iovs.02-0357","article-title":"Human Corneal Epithelial Cells Express Functional PAR-1 and PAR-2","volume":"44","author":"Lang","year":"2003","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_103","first-page":"e2991","article-title":"Role of Protease-Activated Receptors 2 (PAR2) in Ocular Infections and Inflammation","volume":"2","author":"Tripathi","year":"2014","journal-title":"Recept. Clin. Investig."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"27215","DOI":"10.1074\/jbc.M114.599712","article-title":"Cathepsin S Causes Inflammatory Pain via Biased Agonism of PAR2 and TRPV4","volume":"289","author":"Zhao","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Klinngam, W., Fu, R., Janga, S., Edman, M., and Hamm-Alvarez, S. (2018). Cathepsin S Alters the Expression of Pro-Inflammatory Cytokines and MMP-9, Partially through Protease\u2014Activated Receptor-2, in Human Corneal Epithelial Cells. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113530"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1742-7843.2012.00896.x","article-title":"A Highly Soluble Matrix Metalloproteinase-9 Inhibitor for Potential Treatment of Dry Eye Syndrome","volume":"111","author":"Mori","year":"2012","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/chem.201504355","article-title":"A Divalent PAMAM-Based Matrix Metalloproteinase\/Carbonic Anhydrase Inhibitor for the Treatment of Dry Eye Syndrome","volume":"22","author":"Richichi","year":"2016","journal-title":"Chem. Eur. J."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/02713683.2020.1782943","article-title":"In Vivo Effect of RSH-12, a Novel Selective MMP-9 Inhibitor Peptide, in the Treatment of Experimentally Induced Dry Eye Model","volume":"46","author":"Shoari","year":"2021","journal-title":"Curr. Eye Res."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Liu, X., Lin, Z., Zhou, T., Zong, R., He, H., Liu, Z., Ma, J., Liu, Z., and Zhou, Y. (2011). Anti-Angiogenic and Anti-Inflammatory Effects of SERPINA3K on Corneal Injury. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016712"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1167\/iovs.12-10145","article-title":"Serine Protease Inhibitor A3K Protects Rabbit Corneal Endothelium From Barrier Function Disruption Induced by TNF-\u03b1","volume":"54","author":"Hu","year":"2013","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1167\/iovs.13-13546","article-title":"Serine Protease Inhibitor A3K Suppressed the Formation of Ocular Surface Squamous Metaplasia in a Mouse Model of Experimental Dry Eye","volume":"55","author":"Lin","year":"2014","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_112","first-page":"257","article-title":"A Mouse Dry Eye Model Induced by Topical Administration of Benzalkonium Chloride","volume":"17","author":"Lin","year":"2011","journal-title":"Mol. Vis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1073\/pnas.90.4.1526","article-title":"Pigment Epithelium-Derived Factor: Neurotrophic Activity and Identification as a Member of the Serine Protease Inhibitor Gene Family","volume":"90","author":"Steele","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_114","first-page":"154","article-title":"Localization of Pigment Epithelium Derived Factor (PEDF) in Developing and Adult Human Ocular Tissues","volume":"7","author":"Karakousis","year":"2001","journal-title":"Mol. Vis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jtos.2020.05.002","article-title":"Pigment Epithelium-Derived Factor Secreted by Corneal Epithelial Cells Regulates Dendritic Cell Maturation in Dry Eye Disease","volume":"18","author":"Singh","year":"2020","journal-title":"Ocul. Surf."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jtos.2020.12.007","article-title":"Pigment Epithelium-Derived Factor (PEDF) Plays Anti-Inflammatory Roles in the Pathogenesis of Dry Eye Disease","volume":"20","author":"Ma","year":"2021","journal-title":"Ocul. Surf."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1021\/jm700962j","article-title":"Small, Potent, and Selective Diaryl Phosphonate Inhibitors for Urokinase-Type Plasminogen Activator with In Vivo Antimetastatic Properties","volume":"50","author":"Joossens","year":"2007","journal-title":"J. Med. Chem."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.exer.2016.03.006","article-title":"Optimization and Validation of an Existing, Surgical and Robust Dry Eye Rat Model for the Evaluation of Therapeutic Compounds","volume":"146","author":"Joossen","year":"2016","journal-title":"Exp. Eye Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ajpath.2021.01.003","article-title":"Pigment Epithelium\u2013Derived Factor Enhances the Suppressive Phenotype of Regulatory T Cells in a Murine Model of Dry Eye Disease","volume":"191","author":"Singh","year":"2021","journal-title":"Am. J. Pathol."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Saarinen, N.V.V., Stone, V.M., Hankaniemi, M.M., Mazur, M.A., Vuorinen, T., Flodstr\u00f6m-Tullberg, M., Hy\u00f6ty, H., Hyt\u00f6nen, V.P., and Laitinen, O.H. (2020). Antibody Responses against Enterovirus Proteases Are Potential Markers for an Acute Infection. Viruses, 12.","DOI":"10.3390\/v12010078"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Costanzi, E., Kuzikov, M., Esposito, F., Albani, S., Demitri, N., Giabbai, B., Camasta, M., Tramontano, E., Rossetti, G., and Zaliani, A. (2021). Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro\/3CLpro) and Human Cathepsin-L. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111779"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Clark, I.M. (2010). Identification of Cellular MMP Substrates Using Quantitative Proteomics: Isotope-Coded Affinity Tags (ICAT) and Isobaric Tags for Relative and Absolute Quantification (ITRAQ). Matrix Metalloproteinase Protocols, Humana Press. Methods in Molecular Biology.","DOI":"10.1007\/978-1-60327-299-5"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1021\/cr000033x","article-title":"Serine Protease Mechanism and Specificity","volume":"102","author":"Hedstrom","year":"2002","journal-title":"Chem. Rev."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.scienta.2018.03.009","article-title":"Multiplex Analyses of the Changes of Aromatic Compounds during the Development of Peach Fruit Using GC\u2013MS and ITRAQ Proteomic Techniques","volume":"236","author":"Zhou","year":"2018","journal-title":"Sci. Hortic."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev.biochem.75.101304.124125","article-title":"Activity-Based Protein Profiling: From Enzyme Chemistry to Proteomic Chemistry","volume":"77","author":"Cravatt","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Peng, H., and Hulleman, J.D. (2019). Prospective Application of Activity-Based Proteomic Profiling in Vision Research-Potential Unique Insights into Ocular Protease Biology and Pathology. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20163855"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal Structure of SARS-CoV-2 Main Protease Provides a Basis for Design of Improved a-Ketoamide Inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/17\/9795\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:19:29Z","timestamp":1760141969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/17\/9795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":127,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["ijms23179795"],"URL":"https:\/\/doi.org\/10.3390\/ijms23179795","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,29]]}}}